The brain-computer interface (BCI) is not merely an advanced technology but also represents a profound revolution spanning neuroscience, artificial intelligence, computer science, philosophy, and sociology. The core value of BCI lies in its ability to break through the informational barriers between the brain and the external world, endowing humans with novel capabilities for information interaction and propelling the evolution of an intelligent society. As a disruptive technological innovation, BCI fundamentally alters the way humans interact with the world, and its applications will profoundly influence our understanding of cognition, consciousness, and even self-existence. For neurosurgery, BCI is not only a revolutionary therapeutic tool but also an opportunity to reshape traditional medical paradigms. From repairing neural damage to modulating brain functions, from enhancing human intelligence to shaping the future of human-machine integration, BCI offers unprecedented possibilities for neurosurgery. The development of this technology not only aids in a deeper understanding of brain functions but also provides robust support for future intelligent healthcare. The impact of BCI extends far beyond medicine, influencing the transformation of future computing paradigms, the proliferation of intelligence augmentation, the scrutiny of social ethics, the deployment of national strategies, the dynamics of economic development, and the safeguarding of national security.

Aging is an inevitable, physiological process of the human body, leading to deterioration in bodily function and increased susceptibility to various diseases. Effective endogenous therapeutic strategies for anti-aging and related diseases remain limited. Exercise confers multifaceted benefits to physical health by augmenting osteogenic and myogenic processes, enhancing cardiovascular and nervous system function, and attenuating chronic inflammation. Angiogenesis and lymphangiogenesis play pivotal roles in anti-aging, tissue repair, and immune response modulation, underscoring their potential as therapeutic targets for age-related diseases. Modulating angiogenic and lymphangiogenic pathways may provide a promising strategy for mitigating vascular decline and immune system dysfunction associated with aging. Exercise-induced endogenous angiogenesis and lymphangiogenesis can exert beneficial effects on physiological function, thereby representing a potential therapeutic paradigm for combating age-related decline and diseases. This review offers a thorough summary of the present knowledge regarding angiogenesis and lymphangiogenesis induced by exercise, encompassing the underlying mechanisms and the effects in different organs. In addition, it explores the potential of physical activity as a non-pharmacological intervention for anti-aging strategies and disease management, offering novel insights into the intersection of physical activity, aging, and disease progression.
Humans ; Lymphangiogenesis/physiology* ; Aging/physiology* ; Exercise/physiology* ; Animals ; Neovascularization, Physiologic/physiology* ; Angiogenesis

Humans ; Brain-Computer Interfaces ; Consciousness Disorders ; Consciousness ; Electroencephalography ; Brain

Spasticity is a kind ofdyskinesia that often occurs after central nervous system injury.The reason for its occurrence is caused by lack of control and recombination of pyramidal system and extrapyramidal nerve fibers,and often leads to increased tension and hyperreflexia of affected muscle groups.For patients with chronic disorders of consciousness (DoC) after brain injury,the occurrence of such symptoms is very common,but effective treatment is rarely reported.The current treatment mainly includes intrathecal injection of baclofen and soft splint to solve joint contracture.Other therapeutic schemes still need further research,including acupuncture,botulinum toxin injection,and deep brain electrical stimulation.This article is summarized as follows.

With the development of modern international medicine, the subject of disorders of consciousness (DOCs) has begun to be raised in mainland China. Much progress has been made to date in several specialties related to the management of chronic DOC patients in China. In this article, we briefly review the present status of DOC studies in China, specifically concerning diagnosis, prognosis, therapy, and rehabilitation. The development of DOC-related scientific organizations and activities in China are introduced. Some weaknesses that need improvement are also noted. The current program provides a good foundation for future development.
China ; Consciousness Disorders ; diagnosis ; therapy ; Humans

Objective To evaluate the impact of the re-modified Sugiura procedure on portal hemodynamics and liver function in cirrhotic patients with portal hypertension.Methods Forty patients with cirrhosis and portal hypertension who underwent the re-modified Sugiura procedure in the Yichang Second People's Hospital from June 2006 to October 2014 were studied.Changes in the free portal pressure (FPP),portal venous flow (PVF) and liver functions before and after operation were analyzed.Results (1) The FPP at different phases of the operation (after opening the abdomen,after splenectomy,and after devascularization) were (43.2 ± 1.8) cmH2O,(34.8 ± 1.6) cmH2O and (35.2 ± 1.7) cmH2O,respectively.There were significant differences in FPP between the phases of after splenectomy and after opening the abdomen,as well as after devascularization and after opening the abdomen (P ＜ 0.05).There was no significant difference in FPP between after devascularization and after splenectomy (P ＞ O.05).(2) The PVF,which were measured with Doppler sonography at 4 time points (preoperative 1 day,postoperative 10 days,postoperative 6 months,postoperative 18 months),were (1 420.4 ± 137.7) ml/min,(1 205.2 ± 126.7) ml/min,(875.8 ± 118.0) ml/min and (893.8 ± 114.7) n1/min,respectively.There were significant differences in PVF between postoperative 10 days and preoperative 1 day,between postoperative 6 months and postoperative 10 days,as well as between postoperative 18 months and preoperative 1 day (P ＜0.05).There was no significant difference in PVF between postoperative 18 months and postoperative 6 months (P ＞0.05).(3)The liver functions were evaluated using the Child-Pugh score at 4 time points (preoperative 1 day,postoperative 10 days,postoperative 6 months,postoperative 18 months).There were no significant differences among the time points,(P ＞ 0.05).Conclusion The re-modified Sugiura's procedure durably,appropriately and effectively reduced the PVF and FPP,but it did not have any negative effects on the liver functions of patients with cirrhosis.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System (CNS) uses molecular parameters in addition to histology to define many tumor entities,thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era.As such,the 2016 CNS WHO presents major restructuring of the diffuse gliomas,medulloblastomas and other embryonal tumors,and incorporates new entities those are defined by both histology and molecular features,including IDH-wildtype glioblastoma,IDH-mutant glioblastoma,H3 K27 M-mutant diffuse midline glioma,RELA fusion-positive ependymoma,WNT-activated medulloblastoma,SHH-activated medulloblastoma,and C19MC-altered embryonal tumor with multilayered rosettes.The 2016 edition has added newly recognized neoplasms,and has deleted some entities,variants and patterns that no longer have diagnostic and/or biological relevance.Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded.Overall,it is hoped that the 2016 CNS WHO will facilitate clinical,experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.

Objective:To prepare and screen monoclonal antibodies against Herpes simplex virus-1(HSV-1),and develop a double antibody sandwich quantitative enzyme-linked immunosorbent assay( Q-ELISA) for detection of HSV-1 particle. This method was used to control the quality of viral particle in the developing and manufacturing process of HSV-1. Methods: BALB/c mice was immunized with HSV-1 to prepare monoclonal antibodies. A double antibody sandwich Q-ELISA was developed to determine concentration of HSV-1 particle,which was based on the neutralizing monoclonal antibody 1F6 as capture antibody,and 2B1 as HRP-conjugated antibody. The performance of the reagent was evaluated,including specificity,sensitivity,precision,accuracy and linear. And the relation between the amount of virus detected by this method and the virus titer was analyzed by regression analysis method. Results: The Q-ELISA for HSV-1 particle was developed. The quantitation scope was 0. 125-2 μg/ml, the coefficient correlation was 0. 995 5, the limit of detection was 0. 125 μg/ml, the recovery was between 85. 6% and 107. 1%, the variation coefficient was lower than 10%, and the reagent does not react with other samples except HSV-1 antigen. This method has a good correlation with virus titer. Conclusion:The Q-ELISA for HSV-1 particle was successfully developed,which provide a new approach for rapid and quantitative detection of HSV-1 antigen.

Objective To analyze the clinical characteristics ,treatment and outcome of Ebola virus disease so as to provide early clinical recognition and treatment for this disease .Methods The clinical manifestations and treatment of 5 cases of Ebola virus disease in Ebola Holding Center of Sierra‐Leone China Friendship Hospital from 15 March 2015 to 15 May 2015 were retrospectively analyzed .And the clinical characteristics and possible effective treatment were discussed combined with related literature . Results Five patients were diagnosed with Ebola virus disease by polymerase chain reaction and 4 cases of 5 patients had confirmed contact history ,while 1 case had no clear contact history .All the 5 cases presented with low fever ,headache and joint pain .Three cases then progressed into severe gastrointestinal symptoms such as nausea ,vomiting ,diarrhea and hypovolemic shock .The patients presented with fast heart rate and shortness of breath and other inflammatory response syndrome in acute phase .One patient rapidly progressed to liver pain ,jaundice and anuria ,then died .Three severe cases recovered after treated with fluid resuscitation ,circulation maintenance and electrolyte balance in acute phase .Conclusions The early symptoms of Ebola virus disease are low fever ,joint pain and nausea .Frequent vomiting ,diarrhea , low blood pressure and electrolyte disorder indicate severe conditions .Shock and electrolyte disorder are deadly complications .Early recognition ,diagnosis and treatment are the key to improve the prognosis .

Brain Infarction ; surgery ; Brain Ischemia ; surgery ; Cerebral Revascularization ; Humans ; Middle Cerebral Artery ; surgery ; Postoperative Period ; Retrospective Studies ; Temporal Arteries ; surgery